MetLife (MET) Financials

MetLife’s latest statements show a business with stronger scale and recurring premium growth, but also rising liabilities, volatile investment results and weaker sequential earnings. The company reported $19.4 billion of revenue in Q2 2026, up from $17.6 billion in the restated Q2 2025 results. Net income attributable to common shareholders increased modestly to $705 million from $698 million, while diluted earnings per share rose to $1.09 from $1.03, helped in part by a lower share count.

• Revenue and premiums continue to expand. Q2 2026 revenue rose approximately 10% year over year, while premiums earned increased 6% to $11.4 billion. Premiums were also higher than the $10.1 billion reported in Q1 2024, indicating long-term growth in the insurance business.
• Investment income remains a major earnings contributor. Net realized and unrealized investment gains reached $5.5 billion in Q2 2026, up from $4.6 billion in Q2 2025 and $2.7 billion in Q3 2023. However, this income stream can fluctuate significantly with market conditions.
• Operating cash flow remains positive. MetLife generated $2.2 billion of operating cash flow in Q2 2026, broadly consistent with the $2.2 billion produced in Q2 2025. Operating cash flow has remained positive in every reported quarter provided, although it varies substantially from quarter to quarter.
• Share repurchases have reduced the share count. The weighted average diluted share count fell to 635.5 million in Q2 2026 from 665.0 million in Q2 2025 and 700.3 million in Q2 2024. Continued buybacks can support earnings per share when net income is stable.
• Common dividends have increased gradually. The dividend per common share rose to $0.593 in Q2 2026 from $0.568 in both Q1 2026 and Q2 2025, compared with $0.50 in 2023 and early 2024. The company also paid $414 million in common dividends during the quarter.
• The balance sheet has expanded. Total assets reached $759.4 billion in Q2 2026, up from $702.5 billion in Q2 2025 and $663.1 billion at year-end 2022. Trading account securities increased to $337.9 billion, reflecting a larger investment portfolio.
• Q2 earnings weakened considerably from Q1. Net income attributable to common shareholders declined from $1.14 billion in Q1 2026 to $705 million in Q2, while diluted EPS fell from $1.74 to $1.09. The decline occurred despite higher investment gains, as premiums fell and insurance claims and total expenses increased.
• MetLife’s results are highly dependent on investment markets. Investment gains have been positive in every income statement period supplied, but they have ranged from approximately $2.7 billion to $5.9 billion. Investors should distinguish market-driven gains from the more recurring premium and service-charge businesses.
• Insurance claims and expenses are rising alongside revenue. Q2 2026 property and liability insurance claims rose 9% year over year to $14.4 billion, while total non-interest expenses increased 11% to $18.4 billion. Expenses grew slightly faster than revenue, pressuring the pretax margin to roughly 5.3% from 5.6% in Q2 2025.
• Cash declined sharply during the first half of 2026. Cash and equivalents fell from $22.7 billion at Q1 2026 to $19.3 billion at Q2 2026. The company reported a $5.6 billion quarterly decrease in cash, driven primarily by $8.9 billion of negative investing cash flow and substantial debt repayments.
• Liabilities are growing faster than shareholder equity. Total liabilities increased to $731.4 billion in Q2 2026 from $674.5 billion in Q2 2025, while total equity declined slightly to $27.7 billion from $27.9 billion. As a result, liabilities represented approximately 96% of total assets, leaving a relatively narrow common-equity cushion.
• Debt repayments have required significant cash. MetLife repaid $27.0 billion of debt in Q2 2026 and $24.7 billion in Q1. Although debt reduction can improve long-term financial flexibility, these repayments contributed to negative changes in cash and were only partly offset by debt issuance and other financing activity.

Overall, MetLife’s multi-year trend is mixed but constructive: assets, premiums and investment securities have grown substantially since 2022, and the declining share count has supported per-share results. However, common equity remains below 2022 levels, liabilities continue to rise and quarterly earnings remain sensitive to investment gains, claims and capital-market conditions. Retail investors should focus on whether premium growth and operating cash flow can continue to offset rising claims and financing needs.